HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liang N Zhang Selected Research

Doxorubicin (Adriamycin)

12/2004Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liang N Zhang Research Topics

Disease

2Infections
09/2005 - 12/2004
2Cystic Fibrosis (Mucoviscidosis)
09/2005 - 12/2004
1Lung Diseases (Lung Disease)
12/2004

Drug/Important Bio-Agent (IBA)

1Messenger RNA (mRNA)IBA
09/2005
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
09/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2004
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2004

Therapy/Procedure

1Therapeutics
12/2004